President Trump’s executive order on pharmaceutical pricing is a wake-up call. For pharma companies, the question is not whether or not to react—but how. And how pharma companies react will have a big impact on where this debate ends. Reframe the narrative right and they have a unique opportunity to shift the conversation and become champions of both innovation and accessibility. Here’s thoughtful guidance for a constructive response.

Continue reading →

With the administration’s increased focus on pharma and healthcare, companies across these sectors need to be ready to engage and communicate their side of the story. Many companies are looking for guidance in their messaging response to the healthcare executive order and the broader policy landscape, from tariffs to MAHA initiatives. Should your company address this directly or let the industry associations take it on? Lee Carter sheds some much-needed light on this question, with the warning: if you don’t tell your story, someone else will. And it will not be to your advantage. 

Continue reading →

It’s a chaotic time in America. Trust is shattered. People are angry. From DEI and tariffs, to rising prices, excessive profits, and broken promises, people on the left and the right believe our system is broken—and that dramatic change needs to happen. And business is getting the brunt of it. Companies need to respond to shift the conversation in their favor. In this eye-opening piece, Lee Carter shares how it’s time for a new way forward, with actionable insights to help you thrive in this new environment.

Continue reading →

Lee Carter recently sat down with our friends at OmnicomHealth for an insightful conversation on the art of effective communication, the role of emotion in persuasion, and how to craft compelling narratives while building trust. The conversation was captured, designed, and packaged in an easy-to-read / easy-to-download format you’ll enjoy!

Continue reading →